Bicocca Open Archive

Logo unimib boa
GRITTI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.139
AS - Asia 2.634
EU - Europa 1.124
SA - Sud America 408
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 72
OC - Oceania 1
Totale 7.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.950
SG - Singapore 758
VN - Vietnam 701
IT - Italia 476
CN - Cina 448
BR - Brasile 312
HK - Hong Kong 279
RU - Federazione Russa 152
BD - Bangladesh 117
CA - Canada 108
DE - Germania 76
SE - Svezia 70
GB - Regno Unito 69
KR - Corea 67
IN - India 65
IE - Irlanda 63
FR - Francia 56
ID - Indonesia 36
AR - Argentina 33
UA - Ucraina 30
ZA - Sudafrica 30
MX - Messico 29
TR - Turchia 26
ES - Italia 22
NL - Olanda 21
PH - Filippine 18
PK - Pakistan 17
FI - Finlandia 16
JP - Giappone 16
PL - Polonia 16
SA - Arabia Saudita 15
EC - Ecuador 14
IQ - Iraq 11
UZ - Uzbekistan 11
VE - Venezuela 11
MA - Marocco 10
AT - Austria 9
CL - Cile 9
UY - Uruguay 9
CO - Colombia 8
CR - Costa Rica 8
KE - Kenya 8
HN - Honduras 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CH - Svizzera 6
DZ - Algeria 6
LB - Libano 6
PT - Portogallo 6
SV - El Salvador 6
AZ - Azerbaigian 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
MY - Malesia 5
NP - Nepal 5
PA - Panama 5
PY - Paraguay 5
EG - Egitto 4
LT - Lituania 4
BB - Barbados 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
NI - Nicaragua 3
PE - Perù 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
IL - Israele 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
MK - Macedonia 1
Totale 7.373
Salva come PNG Salva come JPEG
Città #
Ashburn 433
Singapore 419
San Jose 303
Hong Kong 270
Ho Chi Minh City 213
Hanoi 184
Council Bluffs 137
Hefei 136
Milan 135
Ann Arbor 97
New York 85
Los Angeles 81
Seoul 65
Santa Clara 64
The Dalles 64
Chandler 62
Chicago 62
Dublin 60
Beijing 51
Toronto 49
Frankfurt am Main 45
Woodbridge 43
Dallas 40
Fairfield 38
Rome 37
São Paulo 37
Boardman 35
Lauterbourg 35
Phoenix 31
Houston 30
Buffalo 29
Wilmington 28
Denver 25
Jakarta 25
Da Nang 24
Haiphong 24
Seattle 23
Moscow 20
Princeton 20
Brooklyn 19
Jacksonville 19
Lissone 19
Johannesburg 18
Montreal 17
London 16
Quận Bình Thạnh 16
Tokyo 15
Warsaw 15
Absecon 14
Cambridge 14
Ha Long 14
Washington 14
Atlanta 13
Shanghai 13
Hải Dương 12
Poplar 12
Biloxi 11
Chennai 11
Dearborn 11
Newark 11
Orem 11
Tashkent 11
Biên Hòa 10
Genoa 10
Miami 10
Philadelphia 10
Stockholm 10
Thái Nguyên 10
Tianjin 10
Vũng Tàu 10
Bắc Giang 9
Jeddah 9
Manchester 9
Mexico City 9
Brescia 8
Florence 8
Lawrence 8
Montevideo 8
Mumbai 8
Naples 8
San Francisco 8
Turin 8
Boston 7
Brasília 7
Bắc Ninh 7
Dhaka 7
Figino 7
Munich 7
Nairobi 7
New Delhi 7
Ninh Bình 7
Nuremberg 7
Phủ Lý 7
Rio de Janeiro 7
San Diego 7
Altamura 6
Barnet 6
Belo Horizonte 6
Bergamo 6
Brussels 6
Totale 4.186
Salva come PNG Salva come JPEG
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 504
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study 426
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 339
Development of new therapeutic strategies in mature T-cell non-Hodgkin lymphomas 303
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 267
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 267
Skip pattern approach toward the early access of innovative anticancer drugs 266
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 265
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: A GIMEMA Multicenter Phase II Trial 254
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia 248
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma 209
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 (Leukemia, (2021), 35, 9, (2710-2714), 10.1038/s41375-021-01299-x) 208
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 194
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 182
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy 174
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up 174
Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma 171
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia 170
Genetic and phenotypic attributes of splenic marginal zone lymphoma 163
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study 162
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study 161
Spleen tyrosine kinase/FMS-Like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/ CB-659 161
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 159
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma 156
Chimeric antigen receptor T cells for gamma–delta T cell malignancies 155
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma 147
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences 146
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis 144
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL 140
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma A C 139
Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab 137
DeepMIF: Deep Learning Based Cell Profiling for Multispectral Immunofluorescence Images with Graphical User Interface 129
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma 121
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 110
SAKK38/07 study: Integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model 106
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma 105
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma 96
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- And T-cell lymphoma models 88
Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure 84
Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell–redirected bispecific antibodies 81
Totale 7.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022115 0 0 0 11 15 11 6 17 3 11 15 26
2022/2023209 25 53 25 15 12 34 8 10 20 1 3 3
2023/2024167 7 2 6 13 20 34 34 6 14 6 4 21
2024/20251.012 15 42 26 19 34 121 70 52 117 189 125 202
2025/20264.389 665 445 278 511 448 190 563 156 310 340 167 316
2026/20271.200 121 158 363 558 0 0 0 0 0 0 0 0
Totale 7.511